Back to results
US 11,319,296 B2Granted
DP antagonist
AssigneeOno Pharmaceutical Co., Ltd.
InventorsMasaki Asada, Keisuke Hanada, Satonori Higuchi, Atsushi Naganawa, Yasuhiro Takeda
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeOno Pharmaceutical Co., Ltd.
InventorsMasaki Asada, Keisuke Hanada, Satonori Higuchi, Atsushi Naganawa, Yasuhiro Takeda
Estimating the term…
An object of the present invention is to provide a DP receptor antagonist. A compound represented by general formula (I): (wherein all symbols are as shown in the specification) and a pharmaceutically acceptable salt thereof have DP receptor antagonistic activity and are also highly safe, and thus are useful as active ingredients of pharmaceuticals for DP receptor-mediated diseases. In addition, the compound represented by the general formula (I) and the pharmaceutically acceptable salt thereof also have good transferability to the central nervous system, and thus are particularly useful as a preventive and/or therapeutic agent for diseases associated with DP receptors present in the central nervous system among DP receptor-mediated diseases, that is, sleep-wake disorders.
{4-Chloro-3-[(2,6-dimethyl-4-{2-[(2R)-oxan-2-yl]ethoxy}benzene-1-carbothioyl)amino]phenyl}acetic acid, or a pharmaceutically acceptable salt thereof.
A compound of the structure formula:
A pharmaceutically acceptable salt of a compound of the structural formula:
Dependencies are inferred from the claim text.